Objective: To investigate the effect of arsenic trioxide (ATO) on EVI1 gene in regulating hematopoietic transcription factors in vitro. Methods: Acute myeloid leukemia cell line with high EVI1 gene expression-THP-1 cell line was chosen to study the relative mRNA expressions of EVI1 gene and hematopoietic transcription factors GATA1, GATA2, RUNX1, MPO, LMO2, CMYB, PU.1 and SCL by reverse transcription-real-time fluorescent quantitative polymerase chain reaction (RFQ-PCR) in vitro. Healthy adult peripheral blood mononuclear cells were used as controls. THP-1 cell line was then treated with ATO solution with concentrations of 1 μmol/L, 3 μmol/L, 5 μmol/L. Then the relative mRNA expressions of EVI1 gene and the above-mentioned hematopoietic transcription factors were re-determined by RFQ-PCR. Results: The expressions of GATA2 and CMYB increased in THP-1 cell line expressing high EVI1 gene, and the levels of GATA1, RUNX1, MPO, LMO2, PU.1 and SCL decreased in vitro. ATO had the ability to down-regulate EVI1 gene in a dose-dependent and time-dependent manner, and the in turn regulatory effect on other hematopoietic transcription factors was observed. Conclusions: THP-1 cells have an increased expression of GATA2 and then indirectly influencing other transcription factors to promote the proliferation of immature cells and inhibit the differentiation and maturation of myeloid and erythroid cells. ATO could specifically down-regulate the expression of EVI1 gene and decrease the activation of GATA2.
ZHU Jianyi, LANG Wenjing, CHEN Fangyuan, XU Zhuoran, SHEN Lijing, ZHONG Jihua
. Effect of arsenic trioxide on EVI1 gene in regulating hematopoietic transcription factors in vitro[J]. Journal of Diagnostics Concepts & Practice, 2017
, 16(01)
: 42
-47
.
DOI: 10.16150/j.1671-2870.2017.01.009
[1] 强琬婷, 诸江. 急性早幼粒细胞白血病小鼠模型中白血病细胞对骨髓基质细胞增殖及功能影响的研究[J]. 诊断学理论与实践,2016,1(15):25-29.
[2] Nucifora G, Laricchia-Robbio L, Senyuk V, et al.EVI1 and hematopoietic disorders: history and perspectives[J]. Gene,2006,368(3):1-11.
[3] Shackelford D, Kenific C, Blusztajn A, et al.Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide[J]. Cancer Res,2006,66(23):11360-11369.
[4] Moriguchi T, Yamamoto M.A regulatory network gover-ning Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation[J]. Int J Hematol,2014, 100(5):417-424.
[5] Yatsula B, Lin S, Read AJ, et al.Identification of bin-ding sites of EVI1 in mammalian cells[J]. J Biol Chem, 2005,280(35):30712-30722.
[6] Suzuki N, Suwabe N, Ohneda O, et al.Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels[J]. Blood,2003,102(10):3575-3583.
[7] Ferreira R, Ohneda K, Yamamoto M, et al.GATA1 function, a paradigm for transcription factors in hematopoiesis[J]. Mol Cell Biol,2005,25(4):1215-1227.
[8] Klempnauer KH, Gonda TJ, Bishop JM.Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene[J]. Cell,1982,31(2 Pt 1):453-463.
[9] Porcher C, Swat W, Rockwell K, et al.The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages[J]. Cell,1996,86(1):47-57.
[10] Hwang LY, Siegelman M, Davis L, et al.Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen[J]. Oncogene,1993,8(11):3043-3046.
[11] Tenen DG.Disruption of differentiation in human cancer: AML shows the way[J]. Nature,2003,3(2):89-101.
[12] Laricchia-Robbio L, Premanand K, Rinaldi CR, et al.EVI1 Impairs myelopoiesis by deregulation of PU.1 function[J]. Cancer Res,2009,69(4):1633-1642.
[13] Yamada Y, Pannell R, Forster A, et al.The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice[J]. Proc Natl Acad Sci U S A,2000,97(1):320-324.
[14] Wadman IA, Osada H, Grütz GG, et al.The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins[J]. EMBO J,1997, 16(11):3145-3157.
[15] Fowler JS, Volkow ND, Logan J, et al.Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations[J]. Synapse,1998,28(2):111-116.
[16] Kalev-Zylinska ML, Horsfield JA, Flores MV, et al.Runx1 is required for zebrafish blood and vessel develop-ment and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis[J]. Development,2002,129(8):2015-2030.
